Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03340311 · ClinicalTrials.gov registry record · NA

Evaluating the Feasibility of Using M-Health to Improve Serum Glucose Logs

A NA study of Gestational Diabetes Mellitus, sponsored by Leslie Balcazar De Martinez.

Completed
Registry status
NA
Development phase
8
Enrollment target
1
Study location

NCT03340311 is a NA study of Gestational Diabetes Mellitus that has completed, run by Leslie Balcazar De Martinez. The registered enrollment target is 8 participants, below the 418-participant average among 16 other Gestational Diabetes Mellitus trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03340311, a NA study of Gestational Diabetes Mellitus, has completed, sponsored by Leslie Balcazar De Martinez.

COMPLETED
Registry status
NA
Development phase
8 participants
Enrollment target
1
Study location

Study Summary

Gestational diabetes mellitus (GDM) can cause adverse outcomes for the mother and fetus due to hyperglycemia. The purpose of this study is to evaluate the feasibility of improving pregnant women's glucose logs using a Bluetooth enabled glucose monitor and associated mobile health application and to assess their satisfaction with using mobile health technology.

Interventions

  • DEVICE iHealth Wireless Smart Gluco- Monitoring System (BG5)

Study Locations (1)

Virginia

  • University of Virginia Maternal Fetal Medicine Clinic - Charlottesville

Trial Details

FieldValue
Enrollment Target 8 participants
Start Date 2017-11-01
Est. Completion 2018-04-28
Phase NA

Sponsor

Leslie Balcazar De Martinez

1 total trials

What the Registry Record Tells You About NCT03340311

The ClinicalTrials.gov registry entry for NCT03340311 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 418-participant average among 16 other Gestational Diabetes Mellitus trials with a reported enrollment target (98% lower). The listed sponsor is Leslie Balcazar De Martinez, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Gestational Diabetes Mellitus appearing as the primary indexed condition, and to 1 intervention - of which iHealth Wireless Smart Gluco- Monitoring System (BG5) is the first listed.

NCT03340311 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.

Frequently Asked Questions

What is clinical trial NCT03340311 about?

NCT03340311 is a clinical study titled "Evaluating the Feasibility of Using M-Health to Improve Serum Glucose Logs". Gestational diabetes mellitus (GDM) can cause adverse outcomes for the mother and fetus due to hyperglycemia. The purpose of this study is to evaluate the feasibility of improving pregnant women's glucose logs using a Bluetooth enabled glucose monitor and associated mobile health application and to ...

What is the current status of trial NCT03340311?

This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2017-11-01. Estimated completion is 2018-04-28.

What conditions does trial NCT03340311 study?

This clinical trial studies the following conditions: Gestational Diabetes Mellitus.

What interventions are being tested in trial NCT03340311?

The interventions under investigation include: iHealth Wireless Smart Gluco- Monitoring System (BG5) (DEVICE).

Who is sponsoring clinical trial NCT03340311?

This trial is sponsored by Leslie Balcazar De Martinez, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03340311 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Gestational Diabetes Mellitus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.